Skip to main content

Table 1 Correlation between the clinicopathological features and expression of HOXD-AS1

From: Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling

clinicopathological variables

N

high(%)

low(%)

χ2

P value

All cases

150

56

94

Age

  < mean (56)

71

24 (33.8)

47 (66.2)

0.718

0.405

  ≥ mean (56)

79

32 (40.5)

47 (59.5)

Gender

 Male

89

33 (37.1)

56 (62.9)

  

 Female

61

23 (37.7)

38 (62.3)

0.006

1

Tumor Size

  < 5 cm

96

40 (41.7)

56 (58.3)

2.14

0.162

  ≥ 5 cm

54

16 (29.6)

38 (70.4)

Tumor Differentiation

 Well

45

22 (48.9)

23 (51.1)

6.121

0.047

 Moderate

75

28 (37.3)

47 (62.7)

 Poor

30

6 (20.0)

24 (80.0)

T classification

 T1-T2

40

19 (47.5)

21 (52.5)

6.096

0.047

 T3

98

36 (36.7)

62 (63.3)

 T4

12

1 (8.3)

11 (91.7)

N classification

 N0

85

38 (44.7)

47 (55.3)

4.557

0.033

 N1-N2

65

18 (27.7)

47 (72.3)

M classification

 M0

113

48 (42.5)

65 (57.5)

4.637

0.031

 M1

37

8 (21.6)

29 (78.4)